Literature DB >> 34170433

Financial Incentives for Pediatric HIV Testing (FIT): Caregiver Insights on Incentive Mechanisms, Focus Populations, and Acceptability for Programmatic Scale Up.

Junyi Zhang1, Dana L Atkins2, Anjuli D Wagner2, Irene N Njuguna2,3, Jillian Neary4, Vincent O Omondi5, Verlinda A Otieno5, Winnie O Atieno5, Merceline Odhiambo5, Dalton C Wamalwa6, Grace John-Stewart2,4,7,8, Jennifer A Slyker2,4, Bryan J Weiner9,2, Kristin Beima-Sofie2.   

Abstract

Children living with HIV experience gaps in HIV testing globally; scaling up evidence-based testing strategies is critical for preventing HIV-related mortality. Financial incentives (FI) were recently demonstrated to increase uptake of pediatric HIV testing. As part of this qualitative follow-up study to the FIT trial (NCT03049917) conducted in Kenya, 54 caregivers participated in individual interviews. Interview transcripts were analyzed to identify considerations for scaling up FI for pediatric testing. Caregivers reported that FI function by directly offsetting costs or nudging caregivers to take action sooner. Caregivers found FI to be feasible and acceptable for broader programmatic implementation, and supported use for a variety of populations. Some concerns were raised about unintended consequences of FI, including caregivers bringing ineligible children to collect incentives and fears about the impact on linkage to care and retention if caregivers become dependent on FI.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Behavioral economics; Financial incentive; Implementation science; Pediatric HIV testing; Scale up

Mesh:

Year:  2021        PMID: 34170433      PMCID: PMC9361631          DOI: 10.1007/s10461-021-03356-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  25 in total

Review 1.  Economic strengthening for HIV testing and linkage to care: a review of the evidence.

Authors:  Mandy Swann
Journal:  AIDS Care       Date:  2018

Review 2.  Conditional economic incentives to improve HIV prevention and treatment in low-income and middle-income countries.

Authors:  Omar Galárraga; Sandra G Sosa-Rubí
Journal:  Lancet HIV       Date:  2019-10       Impact factor: 12.767

3.  Brief Report: Use of the Consolidated Framework for Implementation Research (CFIR) to Characterize Health Care Workers' Perspectives on Financial Incentives to Increase Pediatric HIV Testing.

Authors:  Dana L Atkins; Anjuli D Wagner; Junyi Zhang; Irene N Njuguna; Jillian Neary; Vincent O Omondi; Verlinda A Otieno; Kenneth Ondeng'e; Dalton C Wamalwa; Grace John-Stewart; Jennifer A Slyker; Kristin Beima-Sofie
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.731

4.  Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.

Authors:  Harsha Thirumurthy; Alex Ndyabakira; Kara Marson; Devy Emperador; Moses Kamya; Diane Havlir; Dalsone Kwarisiima; Gabriel Chamie
Journal:  Lancet HIV       Date:  2019-01-16       Impact factor: 12.767

5.  Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).

Authors:  Wafaa M El-Sadr; Deborah Donnell; Geetha Beauchamp; H Irene Hall; Lucia V Torian; Barry Zingman; Garret Lum; Michael Kharfen; Richard Elion; Jason Leider; Fred M Gordin; Vanessa Elharrar; David Burns; Allison Zerbe; Theresa Gamble; Bernard Branson
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

6.  Cash incentives versus defaults for HIV testing: A randomized clinical trial.

Authors:  Juan Carlos C Montoy; William H Dow; Beth C Kaplan
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

7.  Financial incentives to increase pediatric HIV testing: a randomized trial.

Authors:  Irene N Njuguna; Anjuli D Wagner; Jillian Neary; Vincent O Omondi; Verlinda A Otieno; Anita Orimba; Cyrus Mugo; Joseph B Babigumira; Carol Levin; Barbra A Richardson; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace John-Stewart; Jennifer Slyker
Journal:  AIDS       Date:  2021-01-01       Impact factor: 4.632

8.  Non-Uptake of HIV Testing in Children at Risk in Two Urban and Rural Settings in Zambia: A Mixed-Methods Study.

Authors:  Sonja Merten; Harriet Ntalasha; Maurice Musheke
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

9.  Financial Incentives to Increase Uptake of Pediatric HIV Testing (FIT): study protocol for a randomised controlled trial in Kenya.

Authors:  Anjuli D Wagner; Irene N Njuguna; Jillian Neary; Vincent O Omondi; Verlinda A Otieno; Joseph Babigumira; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace C John-Stewart; Jennifer A Slyker
Journal:  BMJ Open       Date:  2018-10-03       Impact factor: 2.692

10.  HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial.

Authors:  Augustine T Choko; Elizabeth L Corbett; Nigel Stallard; Hendramoorthy Maheswaran; Aurelia Lepine; Cheryl C Johnson; Doreen Sakala; Thokozani Kalua; Moses Kumwenda; Richard Hayes; Katherine Fielding
Journal:  PLoS Med       Date:  2019-01-02       Impact factor: 11.069

View more
  2 in total

1.  Brief Report: Pediatric Saliva-Based HIV Testing: Health care Worker and Caregiver Acceptability.

Authors:  Jillian Neary; Michelle A Bulterys; Emily A Ogutu; Gabrielle O'Malley; Anita A Otieno; Vincent O Omondi; Yu Wang; Xinyi Zhai; David A Katz; Laura Oyiengo; Dalton C Wamalwa; Jennifer A Slyker; Grace C John-Stewart; Irene N Njuguna; Anjuli D Wagner
Journal:  J Acquir Immune Defic Syndr       Date:  2022-08-15       Impact factor: 3.771

Review 2.  Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review.

Authors:  Alexsandra Andrawis; James Tapa; Ivo Vlaev; Daniel Read; Kelly Ann Schmidtke; Eric P F Chow; David Lee; Christopher K Fairley; Jason J Ong
Journal:  Curr HIV/AIDS Rep       Date:  2022-08-05       Impact factor: 5.495

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.